Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 9, 2016, Pages E1306-E1315

  Li, Jun ^a   Sung, Cecilia Ying Ju ^a   Lee, Nikki ^b   Ni, Yueqiong ^a   Pihlajamäki, Jussi ^c,d   Panagiotou, Gianni ^a   El Nezami, Hani ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Hepatocellular carcinoma; IL 17; Metagenome; Probiotics; Th17

Indexed keywords

ANGIOTENSIN I; ANTINEOPLASTIC AGENT; CISPLATIN; DOCOSAHEXAENOIC ACID; DRUG METABOLITE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; GLUCOSE; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 27; INTERLEUKIN 6; PALMITOLEIC ACID; PROBIOTIC AGENT; PROHEP; PROTEIN; STAT4 PROTEIN; TEK PROTEIN; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIUM; BLOOD ANALYSIS; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MIXTURE; FEEDING; GENE SEQUENCE; INTESTINE; INTESTINE FLORA; LIVER CELL CARCINOMA; MALE; METAGENOME; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; OSCILLIBACTER; PREVOTELLA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME; ANIMAL; LIVER TUMOR; MICROBIOLOGY; PATHOLOGY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PROBIOTICS;

EID: 84959314003     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1518189113     Document Type: Article

References (64)

1. IARC (2013) GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 (International Agency for Research on Cancer, Lyon, France).
2. Fernández M, et al. (2009) Angiogenesis in liver disease. J Hepatol 50(3):604-620.
3. Ono M (2008) Molecular links between tumor angiogenesis and inflammation: Inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 99(8):1501-1506.
4. Cua DJ, Tato CM (2010) Innate IL-17-producing cells: The sentinels of the immune system. Nat Rev Immunol 10(7):479-489.
5. Murugaiyan G, Saha B (2009) Protumor vs antitumor functions of IL-17. J Immunol 183(7):4169-4175.
6. Numasaki M, et al. (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101(7):2620-2627.
7. Chauhan SK, et al. (2011) A novel pro-lymphangiogenic function for Th17/IL-17. Blood 118(17):4630-4634.
8. Numasaki M, et al. (2005) IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 175(9):6177-6189.
9. Lee JW, et al. (2008) Differential regulation of chemokines by IL-17 in colonic epithelial cells. J Immunol 181(9):6536-6545.
10. Ivanov II, et al. (2008) Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4(4):337-349.
11. Tanabe S (2013) The effect of probiotics and gut microbiota on Th17 cells. Int Rev Immunol 32(5-6):511-525.
12. Plottel CS, Blaser MJ (2011) Microbiome and malignancy. Cell Host Microbe 10(4):324-335.
13. Berger H, et al. (2013) SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth. Cancer Res 73(12):3578-3590.
14. Augustin R (2010) The protein family of glucose transport facilitators: It's not only about glucose after all. IUBMB Life 62(5):315-333.
15. Bogaerts E, et al. (2015) Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors. PLoS One 10(3):e0119555.
16. Amann T, et al. (2009) GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 174(4):1544-1552.
17. Denko NC (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8(9):705-713.
18. Guinane CM, Cotter PD (2013) Role of the gut microbiota in health and chronic gastrointestinal disease: Understanding a hidden metabolic organ. Therap Adv Gastroenterol 6(4):295-308.
19. Holmes E, Li JV, Marchesi JR, Nicholson JK (2012) Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab 16(5):559-564.
20. Maslowski KM, Mackay CR (2011) Diet, gut microbiota and immune responses. Nat Immunol 12(1):5-9.
21. Ahn J, et al. (2013) Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 105(24):1907-1911.
22. Scanlan PD, et al. (2008) Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 10(3):789-798.
23. Amato KR, et al. (2013) Habitat degradation impacts black howler monkey (Alouatta pigra) gastrointestinal microbiomes. ISME J 7(7):1344-1353.
24. Schwiertz A, et al. (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18(1):190-195.
25. Brown CT, et al. (2011) Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 6(10):e25792.
26. Kverka M, et al. (2011) Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 163(2):250-259.
27. Arpaia N, et al. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504(7480):451-455.
28. Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 107(27):12204-12209.
29. Iida N, et al. (2013) Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342(6161):967-970.
30. Yang ZH, Miyahara H, Hatanaka A (2011) Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis 10:120.
31. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA, Jr, Libby P (1994) The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 14(11):1829-1836.
32. Llovet JM, et al.; SHARP Investigators Study Group (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4):378-390.
33. Ding Y, Xu J, Bromberg JS (2012) Regulatory T cell migration during an immune response. Trends Immunol 33(4):174-180.
34. Murff HJ, et al. (2011) Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: A prospective cohort study. Int J Cancer 128(6):1434-1441.
35. Arima Y, et al. (2012) Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 148(3):447-457.
36. Murakami M, et al. (2011) Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells. J Exp Med 208(1):103-114.
37. Bedoya SK, Lam B, Lau K, Larkin J, 3rd (2013) Th17 cells in immunity and autoimmunity. Clin Dev Immunol 2013:986789.
38. Kim CH (2009) Migration and function of Th17 cells. Inflamm Allergy Drug Targets 8(3):221-228.
39. Zou W, Restifo NP (2010) T (H) 17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 10(4):248-256.
40. Lomax AR, Calder PC (2009) Probiotics, immune function, infection and inflammation: A review of the evidence from studies conducted in humans. Curr Pharm Des 15(13):1428-1518.
41. Smith PM, et al. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341(6145):569-573.
42. Kim JY, Park MS, Ji GE (2012) Probiotic modulation of dendritic cells co-cultured with intestinal epithelial cells. World J Gastroenterol 18(12):1308-1318.
43. Duale N, et al. (2007) Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles. Mol Cancer 6:53.
44. Rosanò L, et al. (2011) Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin Cancer Res 17(8):2350-2360.
45. Nör C, et al. (2014) Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. Neoplasia 16(2):137-146.
46. Sun Z, Wang S, Zhao RC (2014) The roles of mesenchymal stem cells in tumor inflammatory microenvironment. J Hematol Oncol 7:14.
47. Carr BI (2002) Hepatic artery chemoembolization for advanced stage HCC: Experience of 650 patients. Hepatogastroenterology 49(43):79-86.
48. Kröger A, et al. (2001) Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice. Cancer Res 61(6):2609-2617.
49. Wang Q, Garrity GM, Tiedje JM, Cole JR (2007) Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73(16):5261-5267.
50. Peng Y, Leung HC, Yiu SM, Chin FY (2012) IDBA-UD: A de novo assembler for singlecell and metagenomic sequencing data with highly uneven depth. Bioinformatics 28(11):1420-1428.
51. Wilcoxon F (1945) Individual comparisons by ranking methods. Biom Bull 1(6):80-83.
52. Kruis W, et al. (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53(11):1617-1623.
53. Fedorak RN, et al. (2003) VSL3 probiotic mixture induces remission in patients with active ulcerative colitis. Gastroenterology 124(4):A377.
54. Gupta P, Andrew H, Kirschner BS, Guandalini S (2000) Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 31(4):453-457.
55. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14):1754-1760.
56. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215(3):403-410.
57. Quast C, et al. (2013) The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res 41(Database issue):D590-D596.
58. McMurdie PJ, Holmes S (2013) phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8(4):e61217.
59. Wood DE, Salzberg SL (2014) Kraken: Ultrafast metagenomic sequence classification using exact alignments. Genome Biol 15(3):R46.
60. Dixon P (2009) VEGAN, a package of R functions for community ecology. Journal of Vegetation Science 14(6):927-930.
61. Zhu W, Lomsadze A, Borodovsky M (2010) Ab initio gene identification in metagenomic sequences. Nucleic Acids Res 38(12):e132.
62. Tatusov RL, Koonin EV, Lipman DJ (1997) A genomic perspective on protein families. Science 278(5338):631-637.
63. Claudel-Renard C, Chevalet C, Faraut T, Kahn D (2003) Enzyme-specific profiles for genome annotation: PRIAM. Nucleic Acids Res 31(22):6633-6639.
64. Ye Y, Doak TG (2009) A parsimony approach to biological pathway reconstruction/inference for genomes and metagenomes. PLOS Comput Biol 5(8):e1000465.